AscellaHealth
AscellaHealth is a global specialty pharmacy and healthcare services organization that provides technology-enabled, end-to-end commercialization, distribution, patient support and payer-focused pharmacy management solutions for life sciences manufacturers, payers and providers. The company operates a national specialty pharmacy network, hub and patient services, publishes market intelligence on specialty and rare therapies, and maintains international distribution capabilities.
Industries
N/A
Nr. of Employees
small (1-50)
AscellaHealth
AscellaHealth, LLC 1055 Westlakes Drive Suite 200 Berwyn, PA 19312
Products
AscellaHealth Medical Specialty List (PDF)
Published medical specialty formulary list for plan and provider reference.
AscellaHealth Pharmacy Specialty Drug List (PDF)
Published pharmacy specialty drug list for benefit design and management.
2025 Enhanced Formulary (PDF)
Enhanced formulary resource for 2025 to support coverage decisions.
AscellaHealth Medical Specialty List (PDF)
Published medical specialty formulary list for plan and provider reference.
AscellaHealth Pharmacy Specialty Drug List (PDF)
Published pharmacy specialty drug list for benefit design and management.
2025 Enhanced Formulary (PDF)
Enhanced formulary resource for 2025 to support coverage decisions.
Services
Nationwide specialty pharmacy dispensing and patient management through a dedicated specialty pharmacy network.
Enrollment, benefits verification, clinical support and personalized patient outreach to facilitate access and adherence for specialty therapies.
International specialty pharmaceutical wholesale, import/export and distribution services to serve manufacturers and patients across multiple regions.
Strategic market access, payer engagement, formulary support and launch infrastructure for specialty and rare disease products.
Design, publication and maintenance of specialty and Medicare formularies and enhanced formulary tools to inform coverage decisions.
Pharmacy management programs for regional health plans and at-risk providers to manage specialty drug costs and utilization.
Nationwide specialty pharmacy dispensing and patient management through a dedicated specialty pharmacy network.
Enrollment, benefits verification, clinical support and personalized patient outreach to facilitate access and adherence for specialty therapies.
International specialty pharmaceutical wholesale, import/export and distribution services to serve manufacturers and patients across multiple regions.
Strategic market access, payer engagement, formulary support and launch infrastructure for specialty and rare disease products.
Design, publication and maintenance of specialty and Medicare formularies and enhanced formulary tools to inform coverage decisions.
Pharmacy management programs for regional health plans and at-risk providers to manage specialty drug costs and utilization.
Expertise Areas
- Specialty pharmacy operations
- Hub and patient support services
- Commercialization and market access for specialty and rare therapies
- Global specialty drug distribution and wholesale
Key Technologies
- Cloud-based patient management platforms
- AI/ML-driven workflow automation for prior authorization and claims
- Patient communication and adherence platforms
- Data analytics for market access and formulary design
News & Updates
Acquisition to expand global specialty pharmaceutical wholesale and product distribution services across EU, Asia, Africa, Australia and the Americas.
Launch of an additional Optime Care site at AscellaHealth headquarters to support operational growth and partnerships.
Recognition on the Financial Times list of The Americas’ Fastest Growing Companies 2025.
Company representation at an industry conference to discuss access to novel therapies and medicinal products.
Quarterly specialty & rare pipeline digest analyzing new approvals, launches, biosimilars and cell & gene therapies.
Industry overview of AI use cases and cautions across specialty pharmacy, home infusion and payer operations (reprinted with AIS Health).
Acquisition to expand global specialty pharmaceutical wholesale and product distribution services across EU, Asia, Africa, Australia and the Americas.
Launch of an additional Optime Care site at AscellaHealth headquarters to support operational growth and partnerships.
Recognition on the Financial Times list of The Americas’ Fastest Growing Companies 2025.
Company representation at an industry conference to discuss access to novel therapies and medicinal products.
Quarterly specialty & rare pipeline digest analyzing new approvals, launches, biosimilars and cell & gene therapies.
Industry overview of AI use cases and cautions across specialty pharmacy, home infusion and payer operations (reprinted with AIS Health).